// App-Quantinova.ai

5127 : Clinical verification of antitumor autoimmune response in eribulin chemotherapy for breast cancer

Researchers

Presenter

  • Wataru Goto

Principal Investigators

  • Shinichiro Kashiwagi

  • Yuka Asano

  • Kento Kurata

  • Tamami Morisaki

  • Satoru Noda

  • Tsutomu Takashima

  • Naoyoshi Onoda

  • Sayaka Tanaka

  • Masahiko Ohsawa

  • Masaichi Ohira

  • Kosei Hirakawa

Medical Centers

  • Department of Surgical Oncology, Osaka City University, Abeno-ku, Osaka, Japan

  • Department of Surgical Oncology, Osaka City University, Abeno-ku, Osaka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Solute Carrier Family 22 Member 3

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • Eribulin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved